The maintenance dose associated with the NUDT15 TT genotype did not reach statistical significance, as only one patient with the NUDT15 TT genotype continued AZA therapy (0.2 mg ⋅ kg −1 ⋅ d −1 ).
← all excerpts
<i>NUDT15</i> Polymorphism Confer Increased Susceptibility to Thiopurine-Induced Leukopenia in Patients With Autoimmune Hepatitis and Related Cirrhosis.
1
—
—